On the road to recovery:Addressing negative symptoms, cognitive deficits and environmental factors in residential patients with severe mental illness by Stiekema, Anna Petronella Maria
  
 University of Groningen
On the road to recovery
Stiekema, Anna Petronella Maria
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2016
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Stiekema, A. P. M. (2016). On the road to recovery: Addressing negative symptoms, cognitive deficits and
environmental factors in residential patients with severe mental illness. [Groningen]: Rijksuniversiteit
Groningen.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019








Cognitive Adaptation Training (cat) improves functional outcomes in schizophrenia outpa-
tients living in the United States. The effectiveness of cat for patients living outside the us 
as well as for long-term hospitalized patients remains to be determined. In addition, it has 
not yet been studied whether cat can be successful if patients receive the treatment from 
psychiatric nurses. This pilot study investigated the effectiveness and feasibility of cat as a 
nursing intervention in the Netherlands. Thirty schizophrenia patients (long-term hospital-
ized patients: 63%) participated in this study. Sixteen patients received treatment as usual 
(tau) + cat, and fourteen patients received tau. Patients in cat participated in the treatment 
for eight months, consisting of weekly home-visits by a psychiatric nurse, supervised by a 
psychologist. After eight months, cat interventions were integrated in the usual treatment. 
Outcome measures were the Multnomah Community Ability Scale (mcas), the Social and 
Occupational Functioning Scale (sofas), and the Negative Symptom Assessment-Motivation 
subscale (nsa-m). For inpatients, work-related activities were also tracked for 16 months 
after baseline. Patients receiving tau + cat had better scores on the mcas (trend), compared 
to tau patients. Moreover, inpatients’ work-related activities increased in tau + cat, relative 
to tau inpatients, reaching significance after ten months. Improvements on the sofas and 
nsa-m were not significant. These results indicate that cat as a nursing intervention may 
improve outcomes in patients with schizophrenia living in the Netherlands, including long-
term hospitalized patients. However, since the current study was designed for exploratory 
purposes, larger randomized controlled studies are needed to confirm our results and to 
investigate the long-term effects of cat as a nursing intervention systematically.
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The majority of patients with schizophrenia show impairments in most cognitive 
domains1. These cognitive deficits substantially contribute to a long-term functional 
disability. In the last decade, treatments addressing cognitive impairment have 
been receiving increasing attention. While pharmacological treatments have proven 
successful in reducing the positive symptoms2, cognitive improvements following 
antipsychotic treatment have been found to be small3. Cognitive remediation programs 
have shown to be more successful4, but a recent meta-analysis shows only small to 
moderate effect sizes for functional outcomes and states that adjunctive therapy is 
essential for transfer of training to daily life5. A different approach in the treatment 
of cognitive impairment is the use of environmental supports in the living area of the 
patient. Such treatment programs use compensation strategies and external aids (e.g. 
alarms, calendars) to bypass cognitive deficits and negative symptoms, and to improve 
adaptive functioning. Cognitive Adaptation Training (cat) is based on this approach and 
has been very successful in doing so in outpatients in the United States6–8. However, a 
number of questions remain unanswered.
First, it is unclear whether patients outside the us can benefit from cat. The cat 
studies conducted in the us have found large effect sizes with respect to adaptive 
functioning6 and medication adherence9. It can be argued that cat should also lead to 
functional improvements in schizophrenia patients living elsewhere10. However, a recent 
Danish study found no additional effect of cat when added to Assertive Community 
Treatment (act)11, but this study had a number of drawbacks (lower treatment intensity 
and limited neuropsychological evaluation)12. Therefore, a new study is required which 
is more comparable with the us studies, in order to determine the efficacy of cat 
elsewhere.
Second, it remains unknown whether inpatients can benefit from cat. In the 
Netherlands, approximately 11% of the patients with schizophrenia are chronically 
hospitalized13. This institutionalized population may be more treatment-resistant, and 
characterized by a more severe and persistent course of illness14. Cognitive impairments 
may also be more severe, which may imply that this group could benefit from 
compensatory strategies and external aids even more. On the other hand, inpatients 
have already had intensive treatment like an Assertive Community Treatment team and 
may not demonstrate additional benefits from the compensatory strategies used in 
cat. Even though a comparison between in-and outpatients is important, in the current 
study we focused on the general feasibility of the intervention as provided by psychiatric 
nurses and in different mental health care settings. Therefore, in the current study 
we will analyze the results of both groups together. Future studies should specifically 
investigate possible differential effects of the intervention in in- and outpatients.







in patients who have received cat8. Some form of treatment continuation seems 
necessary in order to sustain the functional improvements that are the result of the 
cat interventions. One study shows that gains after treatment (9 months) can be partly 
maintained by means of booster sessions8. In clinical practice, ongoing support may be 
required, by means of the involvement of mental health workers, who are in contact 
with their patients over a longer period of time. In the Netherlands, and countries with 
a similar mental health care system (e.g. Denmark, Germany, Finland), patients with 
severe mental illness have frequent contacts with psychiatric nurses. There are several 
reasons to teach nurses how to provide cat to their patients. Regular home-visits are 
already part of the nurses’ routine, which fits with the cat model. Further, nurses often 
have longer lasting therapeutic relationships with patients compared to psychologists 
or psychiatrists, increasing the chance that cat interventions can be integrated and 
sustained over a longer time period.
Therefore, the aim of the current study was to explore in a pilot investigation 
the additional value of cat as a nursing intervention for a Dutch cohort consisting of 
both inpatients and outpatients with schizophrenia. We expected the addition of cat 
to treatment as usual (tau) to lead to improvements in terms of functional outcome, 
relative to patients receiving only tau.
Methods
Design
Thirty patients receiving mental health care in the Netherlands were included in the 
current study, which was approved by the Medical Ethics Review Committee of the 
University Medical Center Groningen, the Netherlands. Patients were assigned to one 
of the two following treatment conditions: 1) treatment as usual plus cat (tau + cat), 
or 2) treatment as usual (tau). Assignment to the conditions occurred as follows. For 
the inpatient clinic, cat was provided for consecutive patients until 10 patients fully 
participated; then tau patients were recruited for baseline with the understanding 
that cat would be delivered at a later time. Outpatients were randomly assigned to 
either tau + cat or tau and tau patients were placed on a waiting list for cat. Treatment 
groups are described below. cat consisted of on average 45 minute weekly visits by a 
psychiatric nurse, for a duration of eight months. The two nurses, one at the outpatient 
center and one at the inpatient clinic, were supervised by a msc psychologist (P.Q.). 
The two nurses who provided cat had both received a bachelor’s degree in education 
and they both had 16 years of working experience in mental health care. After eight 
months, responsibility for maintaining and creating cat interventions was transferred 
to the patients’ case managers. Patients were assessed at baseline, after four months, 
and after eight months (see Section Assessment). These assessments were conducted 
by a msc psychologist who was blind to the treatment condition, as well as the content 
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of cat. In addition, for the inpatients we also tracked their participation in work-related 
activities, using the data of a registration system at the residential facility. Data for the 
work-related activities were analyzed for 16 months, plus one month for the assessment 
at baseline.
Subjects
Participants were both outpatients and inpatients with a diagnosis within the 
schizophrenia spectrum according to the dsm-iv15. In order to be included, all patients 
had to be between 18 and 65 years of age, and free of alcohol/drug abuse within six 
months prior to inclusion. Information about these criteria was obtained via electronic 
patient records and the patients’ clinician.
Outpatients were recruited from the Department of Psychosis of the University 
Center of Psychiatry, University Medical Center Groningen. This department offers mental 
health care to patients, predominantly in the early stage of the disease. Recruitment of 
institutionalized participants took place at Lentis Mental Health Care, Department of 
Rehabilitation. This department offers on site protected and sheltered living to chronic 
patients who have insufficiently recovered during earlier hospitalizations.
Initially, 36 participants enrolled in the current study. Patients in both centers were 
asked to participate in the pilot study if they reported to have difficulties with respect to 
either cognitive or daily functioning, or a desire to improve their quality of life. Between 
baseline and the first follow-up, two patients discontinued cat, and two tau patients 
died. Further, for two additional tau + cat patients it was not possible to make visits on 
a weekly or biweekly basis due to non-compliance. These patients had missed too many 
visits, thereby affecting treatment fidelity. Therefore, the final analyses were conducted 
on 30 patients: 16 patients (ten inpatients) who received tau + cat and 14 patients (nine 
inpatients) who received no additional interventions to treatment as usual (tau). All 
patients signed informed consent.
Treatment groups
Cognitive Adaptation Training
The assessment and treatment procedures of cat have been described in more detail 
elsewhere6. Briefly, cat is a psychosocial intervention that aims to improve daily 
functioning by bypassing the impact of cognitive deficits and by stimulating functional 
behavior6. The intervention takes place in the patients’ living environment. cat teaches 
compensation strategies and makes use of environmental supports in several areas of 
daily living. Individual treatment plans are based upon information about the individual 
behavioral and cognitive characteristics and specific problem areas in daily life. The 
patients’ behavior type (apathy, disinhibition or mixed) is measured using the Frontal 







will most likely benefit daily functioning (i.e. cueing and prompting behavior [apathy] 
or removing distracting stimuli [disinhibition]). The form of the intervention strategy 
(i.e. size, proximity, specificity, noticeability) is determined by the level of executive 
functioning (poor or fair), measured with Modified Card Sorting Task (mcst17) and 
the Controlled Oral Word Association Test (cowat18). Functional and environmental 
problems are assessed with the Environmental and Functional Assessment19. Commonly 
used environmental supports for cat are signs, calendars, pill containers, watches, 
alarms, and hygiene and cleaning supplies. cat was additional to the usual treatment.
Treatment as usual
tau consists of individually orientated care and treatment, delivered and evaluated 
in a multidisciplinary setting. Besides pharmacotherapy, patients are offered psycho-
education, cognitive behavioral therapy, Liberman modules, psychomotor therapy, 
creative arts therapy, educative projects, several sports groups and peer support 
groups. For inpatients, work projects at the residential area are offered as part of the 
tau, whereas for the outpatients, work rehabilitation is organized according to the 
Individual Placement and Support (ips) model. Treatment contact with psychiatric nurses 
occurred on a daily to weekly basis for the inpatients, and on a weekly to biweekly basis 
for the outpatients. For all patients, treatment and progress were reviewed annually by 
a multidisciplinary team. Participation in these several elements of treatment depends 
on the individual needs and wishes of the patients. Of note, the experimental group 
was offered cat in addition to the therapeutic milieu of tau. The tau group did not 
receive any other interventions in addition to the abovementioned.
Assessments
Descriptives
Demographic information was obtained at baseline. The presence and severity of 
symptoms were assessed using the Positive and Negative Syndrome Scale (panss20). 
This semi-structured interview addresses both psychotic and non-psychotic symptoms, 
including their impact on behavior. The panss consists of three subscales: positive, 
negative, and general symptoms. For each subscale a score can be computed, as well 
as a total score. Higher scores reflect more severity of symptoms. The panss is a widely 
used instrument of which the Dutch translation is validated21.
Functional outcomes
Translations of the outcome measures used in the us studies were adopted for means 
of comparison. The primary outcome was the level of functioning, evaluated using 
the Multnomah Community Ability Scale (mcas22) and the Social and Occupational 
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Functioning Scale (sofas15). The mcas is a 17-item scale assessing a variety of domains 
of community adjustment following a semi-structured interview with the patient, and 
with a psychiatric treatment provider. For the mcas, the total score was used (range 
17–85). The sofas rates social and occupational functioning on a single-item scale 
(range 0–100). The score was given by the blind rater. For both the mcas and the 
sofas, higher scores reflect better functioning. Secondary outcomes were motivation 
to engage in activities and time spent in work-related activities. Motivation to engage 
in activities was assessed using the motivation subscale from the Negative Symptom 
Assessment, a semi-structured interview (nsa-m23). On this scale, higher scores reflect 
lower functioning. For inpatients, the time spent on work-related activities (measured 
in number of partial days a week; a partial day consisted of 3 hours) was registered 
monthly. As defined by the Dutch Health Authorities  (Nederlandse Zorgautoriteit), 
these activities are educative or work activities for patients who are not able to function 
in the community, aimed at rehabilitation and stabilization. In sheltered settings such 
as a framing center, graphic design and copy center, an agrarian project (care farm), 
and a greenery project (site and garden maintenance), patients can participate at their 
own level in activities such as administration, services, gardening, techniques, care for 
animals and plants, maintenance and handling machines and tools. 
The Dutch translations of the functional outcome scales have yet to be validated. 
However, the mcas and sofas are widely used and have been validated in other 
languages22,24. We chose to administer the same scales as earlier cat studies to facilitate 
comparability with earlier cat studies.
Statistical analysis
We examined differences between the tau group and the experimental group (tau + cat). 
Differences between the groups in baseline demographical and clinical characteristics 
were examined with the Fisher’s exact test for categorical and the Mann Whitney U 
test for continuous variables. A population average (e.g. modeling mean scores for tau 
and mean scores for tau + cat) linear mixed model was applied to the outcomes (sofas, 
mcas, nsa-m, and work-related activities) at each time point after baseline (four and 
eight months for sofas, mcas and nsa-m; months 1 to 16 for work-related activities). 
We used restricted maximum likelihood estimation. The analyses were corrected for 
baseline scores to eliminate the effect of possible (average) differences between tau 
+ cat and tau at baseline. An unstructured correlation structure was selected for the 
correlation between the two time point points after baseline (four and eight months) 
for the sofas, mcas and nsa-m. A (heterogeneous) autoregressive correlation structure 
was used for work-related activities, to account for the correlation structure between 
16 time points. Time was modeled as a categorical variable instead of continuous to 













   Diagnosis, #
      Schizophrenia 15 12
      Schizoaffective disorder 1 -
      Psychotic disorder nos - 2
   Gender, # male 13 11
   Nationality, # Dutch 15 10
   Age, years 45.06 ± 12.22 43.50 ± 14.84
   Age of onset, years 30.20 ± 12.56 27.71 ± 12.14
   Educationa 4.63 ± 1.36 4.14 ± 1.29
  Residential status, # inpatient 10 9
   panss,
      Positive 12.67 ± 4.88 15.67 ± 6.01
      Negative 19.53 ± 6.38 20.00 ± 8.38
      General 33.93 ± 8.82 38.58 ± 9.24
   Antipsychotic medication, cpz equivalentb 567.92 ± 402.36 587.37 ± 457.72
      Clozapine 11 4
      Risperidone 2 3
      Olanzapine 2 3
      Quetiapine - 2
      Haloperidol 1 1
      Fluphenazine 1 -
      Zuclopentixol 3 3
      Flupentixol 1 -
      No antipsychotics 1 -
      No antipsychotics - 2
   Concomitant medicationc, #
      Antidepressants 3 2
      Benzodiazepines 5 5
      Anticholinergics 5 3
      Mood stabilizers - 2
      Anti-epileptics 5 1
      Other 1 2
Scores for dependent variables
  sofas 36.94 ± 10.55 38.07 ± 14.33
  mcas 56.44 ± 10.24 55.29 ± 12.77
  nsa-m 16.94 ± 3.99 16.64 ± 5.58
  Work related activitiesd 0.35 ± 0.76 0.97 ± 1.41
Table 1. Baseline 
c h a r a c t e r i s t i c s . 
Table represents 
means ± standard 
deviation or num-
bers. Age of onset 
of one of the pa-
tients in the tau + 
cat condition was 
unknown. For three 
participants (one 
tau+cat, two tau) 
the panss was not 
administered, caus-
ing the number of 
subjects on these 
variables to be 
smaller. aEducation 
(Verhage): range 1 
(no education), 4–5 
(school diploma) 
to 7 (university de-
gree). bDose equiva-
lents of chlorprom-
azine were based 
on Andreasen and 
colleagues25. Four 
patients in tau and 
seven in tau+cat 
took two different 
antipsychotics. cTwo 
patients in tau and 
two in tau+cat 
took two types of 
concomitant med-
ications, two tau 
patients and three 
tau+cat patients 




measured in partial 
days per week (in-
patients only).
patient participated in tau + cat or tau) and the interaction of treatment and time 
were included in the linear mixed model in order to estimate the effect of treatment. 
The treatment effect was essentially estimated for each time point by subtracting the 
estimated mean scores of the tau patients from the estimated mean scores of the tau 
+ cat patients. Thus, the effect size reflects the estimated mean difference between 
the groups at four months and at eight months. These analyses were corrected for 
baseline scores to eliminate a possible (average) difference between tau + cat and tau 
in the outcome measures at baseline. The estimated differences between the groups 
per time point, together with their appropriate confidence intervals, are reported and 
graphically displayed. All analyses were performed using sas.
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Figure 1. The effect 
size at each time 
point reflects the 
mean difference in 
mcas between the 
groups (tau + cat 
minus tau).
Figure 2. The effect 
size at each time 
point reflects the 
mean difference in 
sofas between the 




The demographic and clinical characteristics at baseline are shown in Table 1. There 
were no significant differences between the treatment groups at study entry.
Functional outcomes
The results from the linear mixed model for outcomes mcas, sofas, and nsa-m are 
visualized in Figure 1, Figure 2 and Figure 3, respectively (and listed in Supplementary 
Table 1). No statistically significant effect of tau + cat with respect to tau was 
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Figure 3. The effect 
size at each time 
point reflects the 
mean difference in 
nsa-m between the 
groups (tau + cat 
minus tau).
Figure 4. The effect 
size at each time 
point reflects the 
mean difference 
in work activities 
between the groups 
(tau + cat minus 
tau).
improvement on the mcas and sofas after four months, as visualized in Figure 1 and 
Figure 2. The effects on work-related activities were plotted against the time points as 
shown in Figure 4 (and listed in Supplementary Table 1). From the confidence intervals 
around the effect sizes (i.e. mean differences between tau and tau + cat), it appears 
that cat had a significant effect from the tenth month, although a gradual increase 
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The current study investigated the efficacy of Cognitive Adaptation Training (cat) as 
a nursing intervention for patients with schizophrenia in the Netherlands. cat was 
added to the usual treatment and was compared to treatment as usual, a therapeutic 
milieu in which all patients participate in a customized selection of available treatments 
that best matches their needs, goals and wishes. The studied population included 
both outpatients and inpatients. cat interventions were set up by a psychiatric nurse, 
additional to the patients’ usual care. After eight months, tau + cat patients exhibited 
a trend towards greater improvement in their general functioning compared to the tau 
group. In addition, tau + cat inpatients spent significantly more time in work-related 
activities; after four months a trend was visible, and a significant effect at ten months.
This is the second European study investigating cat for schizophrenia patients11. 
Our findings show promise for cat as a nursing intervention in long-term hospitalized 
patients, and they encourage a larger study investigating the efficacy of cat for 
schizophrenia patients living in a country with a different mental health care system 
than the us, where the treatment was developed. Patients showed a trend towards 
greater improvement in functioning. This is possibly due to the fact that in our study 
the frequency of cat visits, the outcome assessments, and the neuropsychological 
evaluation were comparable to the us studies. Moreover, the principal investigator of 
the current study was trained in the application of cat in the us prior to conducting the 
study. Our expectation is that the improvements on mcas scores would have reached 
statistical significance if measured over a longer time period, as is the case for the 
work-related activities in the inpatient group. This needs to be investigated by further 
research.
Earlier cat studies have only included outpatients. In our study, 63% of the 
included cohort consisted of long-term hospitalized patients with schizophrenia. tau 
+ cat inpatients engaged more in work-related activities with time. The fact that these 
differences became and remained significant after the initial study period (Fig. 4), is 
in line with the suggestion of Onken and colleagues26 that rehabilitation in chronically 
ill patients is possible, but slow. An earlier study conducted in the us has shown that 
improvements in general functioning can be sustained, but that some continuation of 
the interventions is necessary for this8. Since the current pilot study suggests that it is 
feasible for cat to be carried out by nurses, it would be interesting to investigate whether 
implementation of cat into the nurses’ daily working routine leads to sustainable and 
long-term improvements in general functioning of patients.
Inherent to the explorative nature of this pilot study, we should mention a number 
of limitations that need to be addressed in future studies. First, although outpatients 
were randomly allocated to either tau + cat or tau, inpatients were not, possibly causing 







(and were told that they would receive cat in the nearby future). Therefore, differences 
between the inpatient tau + cat and tau groups may be minimal. Nevertheless, the 
results should be interpreted with caution. Furthermore, we do not have information on 
the aspecific effects of cat (e.g. increased attention), which may partly explain the trend 
in improvements on the outcome measures. Since the usual care in the Netherlands is 
already very rich and all patients have contact with nurses on a regular basis, we do not 
expect this to have affected the results. At the same time, as a consequence of the rich 
usual care, the adopted outcome measurements may not have been sensitive enough 
to fully capture these small improvements. The sofas for example is a rather global 
scale that may be less sensitive to change in residential patients. In addition, we did not 
have follow-up measurements of the primary outcome measure (mcas) after the initial 
study period of 8 months. We argue that statistically significant improvements may be 
present after that period, which is supported by our finding that differences in work-
related activities reached statistical significance after the initial study period, namely 
after 10 months. Finally, the small sample size limits generalizability of findings. This 
also left us unable to make comparisons between the inpatient and outpatient group.
Due to the abovementioned study limitations, we should interpret the findings of 
the current pilot study with caution. The results do show promise for cat as a nursing 
intervention. More research in the form of randomized controlled trials is necessary for 
both inpatients and outpatients in countries with other health care systems than in the 
us, addressing the abovementioned limitations.
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Outcome and time Effect size 95% ci Standard error p
mcas
   4 months -0.349 [-2.995 ; 2.298] 1.2898 0.789
   8 months 1.562 [-1.902 ; 5.027] 1.6902 0.363
sofas
   4 months 0.293 [-2.762 ; 3.349] 1.4892 0.845
   8 months 3.436 [-1.366 ; 8.238] 2.3430 0.154
nsa-m
   4 months 0.123 [-1.221 ; 1.467] 0.6552 0.852
   8 months -0.439 [-1.943 ; 1.604] 0.7330 0.554
Work-related activitiesa
   1 month -0.038 [-0.402 ; 0.326] 0.1721 0.827
   2 months -0.193 [-0.878 ; 0.492] 0.3252 0.561
   3 months -0.089 [-0.854 ; 0.675] 0.3576 0.806
   4 months 0.287 [-0.676 ; 1.249] 0.4504 0.535
   5 months 0.353 [-0.832 ; 1.537] 0.5618 0.538
   6 months 0.917 [-0.543 ; 2.377] 0.6945 0.204
   7 months 0.656 [-0.943 ; 2.255] 0.7575 0.399
   8 months 1.065 [-0.384 ; 2.513] 0.6881 0.140
   9 months 1.192 [-0.224 ; 2.608] 0.6786 0.094
   10 months 1.064 [0.076 ; 2.053] 0.4765 0.036
   11 months 1.667 [0.465 ; 2.870] 0.5828 0.009
   12 months 1.982 [0.624 ; 3.341] 0.6611 0.006
   13 months 1.579 [0.496 ; 2.662] 0.5286 0.006
   14 months 1.700 [0.485 ; 2.915] 0.5942 0.008
   15 months 1.446 [0.396 ; 2.496] 0.5147 0.009
   16 months 2.131 [0.755 ; 3.507] 0.6740 0.004
S u p p l e m e n ta ry 
table 1. Effect sizes 
(mean differenc-
es between the 
groups), confidence 
intervals, standard 
errors and p-values 
for the outcome 
measures. aWork 
related activities: 
measured in partial 
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